Product Program year 2022 Source: CMS Open Payments

Covera

Device BD Interventional Peripheral Intervention

PDI 00801741107078

Open in the dashboard

General payments

$15,778

414 payments

Research payments

$667,699

42 payments

Through program year 2022, $15,778 in general payments and $667,699 in research payments were reported against Covera (BD Interventional Peripheral Intervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $15,778 414
2022 Research $315,776 18
2021 Research $351,923 24

Breakdown

Who paid General payments · program year 2022
  1. Bard Peripheral Vascular, Inc. $15,601 405 payments
  2. Becton, Dickinson and Company $177 9 payments
Top recipients General payments · program year 2022
  1. Moiz Dawood Nephrology · Henderson, NV $1,748 11% · 5 payments
  2. Alejandro Alvarez Nephrology · Florissant, MO $983 6% · 19 payments
  3. Tauseef Khan Cardiovascular Disease · Dubuque, IA $819 5% · 6 payments
  4. Rajesh Patel Diagnostic Radiology · Atlantic City, NJ $366 2% · 11 payments
  5. Jeffrey Hoggard Nephrology · Raleigh, NC $328 2% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Nephrology Internal Medicine $6,045 38% · 46 practitioners
  2. Vascular & Interventional Radiology Radiology $3,111 20% · 64 practitioners
  3. Vascular Surgery Surgery $2,205 14% · 44 practitioners
  4. Diagnostic Radiology Radiology $1,248 8% · 34 practitioners
  5. Cardiovascular Disease Internal Medicine $819 5% · 1 practitioner

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. New Jersey $2,787 18% · 31 recipients
  2. Missouri $1,882 12% · 10 recipients
  3. Nevada $1,764 11% · 2 recipients
  4. Illinois $1,548 10% · 25 recipients
  5. North Carolina $1,168 7% · 19 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

414 general · 42 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record